Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Copolymer L-glutamic Acid-l-lysine
2. Glutamic Acid (60)-lysine (40) Copolymer
3. Pgal
4. Poly(glu-lys)
5. Poly(glutamic Acid-lysine)
6. Poly(glutamic Acid-lysine), (d)-isomer
7. Poly-gl
1. 5408-52-6
2. Lysine Glutamate
3. L-lysine L-glutamate Salt
4. (s)-2,6-diaminohexanoic Acid Compound With (s)-2-aminopentanedioic Acid (1:1)
5. 3z47p7xz8d
6. L-glutamic Acid, Compd. With L-lysine (1:1)
7. Poly(glu-lys)
8. Poly-gl
9. Pgal
10. Poly(glutamic Acid-lysine)
11. Unii-3z47p7xz8d
12. Mfcd00038974
13. Nsc-10855
14. Copolymer L-glutamic Acid-l-lysine
15. Einecs 226-474-0
16. Nsc 10855
17. 27456-64-0
18. (2s)-2-aminopentanedioic Acid; (2s)-2,6-diaminohexanoic Acid
19. Glutamic Acid (60)-lysine (40) Copolymer
20. Glutamic Acid, L-, Compd. With L-lysine (1:1)
21. Schembl205003
22. Lysine Glutamate [inci]
23. Lysine L-glutamate, L-
24. Dtxsid50883926
25. Lysine Glutamate [who-dd]
26. L-lysine L-glutamate [mi]
27. Akos015920006
28. Gs-3338
29. L-glutamic Acid, Polymer With L-lysine
30. Am20100333
31. Cs-0186164
32. E76092
33. L-glutamic Acid Compound With L-lysine (1:1)
34. Q27258239
35. (2s)-2,6-diaminohexanoic Acid; (2s)-2-aminopentanedioic Acid
36. (2s)-2-aminopentanedioic Acid;(2s)-2,6-diaminohexanoic Acid
37. (s)-2,6-diaminohexanoic Acid (s)-2-aminopentanedioic Acid Salt
38. (s)-2,6-diaminohexanoicacidcompoundwith(s)-2-aminopentanedioicacid(1:1)
39. (s)-2,6-diaminohexanoic Acid Compound With (s)-2-aminopentanedioic Acid (1:1) (h-l-lys-oh.h-l-glu-oh)
| Molecular Weight | 293.32 g/mol |
|---|---|
| Molecular Formula | C11H23N3O6 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 9 |
| Exact Mass | 293.15868546 g/mol |
| Monoisotopic Mass | 293.15868546 g/mol |
| Topological Polar Surface Area | 190 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 251 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
A L-Lysine L-Glutamate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L-Lysine L-Glutamate, including repackagers and relabelers. The FDA regulates L-Lysine L-Glutamate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L-Lysine L-Glutamate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of L-Lysine L-Glutamate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A L-Lysine L-Glutamate supplier is an individual or a company that provides L-Lysine L-Glutamate active pharmaceutical ingredient (API) or L-Lysine L-Glutamate finished formulations upon request. The L-Lysine L-Glutamate suppliers may include L-Lysine L-Glutamate API manufacturers, exporters, distributors and traders.
click here to find a list of L-Lysine L-Glutamate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
L-Lysine L-Glutamate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of L-Lysine L-Glutamate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right L-Lysine L-Glutamate GMP manufacturer or L-Lysine L-Glutamate GMP API supplier for your needs.
A L-Lysine L-Glutamate CoA (Certificate of Analysis) is a formal document that attests to L-Lysine L-Glutamate's compliance with L-Lysine L-Glutamate specifications and serves as a tool for batch-level quality control.
L-Lysine L-Glutamate CoA mostly includes findings from lab analyses of a specific batch. For each L-Lysine L-Glutamate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
L-Lysine L-Glutamate may be tested according to a variety of international standards, such as European Pharmacopoeia (L-Lysine L-Glutamate EP), L-Lysine L-Glutamate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (L-Lysine L-Glutamate USP).
LOOKING FOR A SUPPLIER?
